<form id="r913x"><form id="r913x"></form></form>

        <em id="r913x"></em>

        <em id="r913x"><form id="r913x"></form></em>

          Products and services

          Products and services

          Ropinirole Hydrochloride Tablets

          適  應  癥: This product is suitable to treat the symptoms and signs of Primary Parkinson’s disease in combination with levodopa.

          規       格:0.5mg, 3mg (by ropinirole)

          包       裝: Laminated film package, 30 tablets/carton

          有  效  期:24 months

          批準文號:0.5mg: National Medicine Standard H20130044
                            3mg: National Medicine Standard H20130045

          - A new generation of selective ergot dopamine receptor agonists;

          - It is recommended as first-line medication for early Parkinson’s treatment by the United States, European and Chinese Parkinson's guidelines.

          - Its efficacy and safety are demonstrated by over-20-year clinical medication experience abroad.

          - The incidence of dyskinesia in early Parkinson's patients is very low, and it can significantly delay the onset of dyskinesia.

          -It assists L-dopa in the treatment of patients with advanced Parkinson’s disease. It can effectively shorten the “day off phenomenon” and reduce 20% of the usage amount of L-dopa.